31 July 2015 – Geneva, Switzerland – The Stop TB Partnership today announced the appointment of Brenda Waning, PhD, MPH, RPh as the new Chief of the Global Drug Facility (GDF). Dr Waning is an expert in developing, implementing, and analyzing pharmaceutical policies and market approaches to improve access to medicines and diagnostics in resource-limited settings. Most recently, Dr Waning was the Coordinator of Market Dynamics at UNITAID where she led efforts related to UNITAID’s technical strategy, market assessments, and strategic investments. Prior to joining UNITAID, Brenda served as Director of Pharmaceutical Policy at Boston University School of Medicine where...
Decisiones de la junta
27/07/201527/07/20150
Las hepatitis virales afectan a millones de personas cada año en el mundo, sin embargo, son en gran medida ignoradas...
22/07/201522/07/20150
Los auditores de la Oficina del Inspector General (OIG) calificaron la gestión de riesgos de los servicios de salud, financieros...
07/07/201507/07/20150
Del 17 al 18 de junio de 2015 se llevó a cabo en Ginebra la 15ª reunión del Comité de...

